Thursday, September 21, 2017 9:55:33 AM
So many breathtaking assumptions though. There is a whole spectrum what that could mean. It could just about mean: Hey Woodford, we are starting P2`s isn´t that nice? And oh, the hold was lifted, so that isn`t an issue any more right Pal? (adding talking through teeth: "after we agreed to not enrol the other 17" cough cough) You should Ockham razor this from time to time, after all you are mr logic. For all we know, Woodford Investment Management was an autofillin from years ago and they just forgot to erase his name, just like they forgot to put up Linda`s bio and photo.
IF they really want his help THEY JUST SHOULD SWALLOW their NARCISSIST PRIDE AND FKN CAAaAAAAAALAAaaaaALLLLL and let him in on one or the other secret like: what was that halt all about
Or you know... If I`m wrong here I appologize. If they are afraid of Woodford taking over. Then don`t write his name on "who should attend" ...
The good thing is, woodford apparently never attends? Did he attend 2015? Or did he only hear about the good data in the info arm on the net?
I`ve heared that attendance this year is low in general. Good job shorts throughing dirt at NWBO for years. Congratz
IF they really want his help THEY JUST SHOULD SWALLOW their NARCISSIST PRIDE AND FKN CAAaAAAAAALAAaaaaALLLLL and let him in on one or the other secret like: what was that halt all about
Or you know... If I`m wrong here I appologize. If they are afraid of Woodford taking over. Then don`t write his name on "who should attend" ...
The good thing is, woodford apparently never attends? Did he attend 2015? Or did he only hear about the good data in the info arm on the net?
I`ve heared that attendance this year is low in general. Good job shorts throughing dirt at NWBO for years. Congratz
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
